The miR-34a for example is downregulated in metastatic HCC tissues, and has been reported to inhibit HCC glycolysis by directly targeting HK1, HK2, and glucose-6-phosphate isomerase (GPI) [153]. Here, HK2 is linked to hepatocellular carcinoma.